Nissen headed a multi-center trial to see if the drug could reduce cholesterol buildup in arteries.
Regular intake of soy protein and the omega-3 fatty acids in tofu, can reduce cholesterol levels by as much as 30% and LDL (bad cholesterol) by 30%-40%.
Making some fairly radical changes in your diet can reduce bad cholesterol by up to 30% in only four weeks, a recent University of Toronto study found.
Dr Tim Bowker, of the British Heart Foundation, said it was already well established that regular physical activity helps improve reduce harmful cholesterol and the risk of atherosclerosis.
James Anderson of the University of Kentucky is working with food companies to put the Toronto study's ingredients into a twice-a-day cereal bar, so people could reduce their cholesterol without having to completely give up meat.
Lipitor will reduce your bad cholesterol by 40% to 50%--but what happens if you don't want to take the drug for the rest of your life?
She said it was also important to remember that regular physical activity combined with a diet high in fruit and vegetables and low in saturated fat was still the best way to combat high cholesterol and reduce the risk of heart disease.
The most promising: a pill called a CETP inhibitor, which raises good cholesterol and may reduce cardiac inflammation and heart disease.
The claim states that a diet rich in whole-grain foods and low in saturated fat and cholesterol may help reduce the risk of heart disease.
Various health studies have shown that eating a handful of almonds every day -- a food high in magnesium, Vitamin E and B2 -- can lower cholesterol and help reduce the risk of heart disease.
KYNAMRO, given as a 200 mg weekly subcutaneous injection, has been approved as an adjunct to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (Apo B), total cholesterol (TC), and non-high density lipoprotein-cholesterol (non HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH).
FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
Physicians have been working hard for years to help patients reduce their "bad" LDL cholesterol.
The addition of Kynamro helps to reduce low-density lipoprotein-cholesterol (LDL-C), apolipoprotein B, total cholesterol, and non-high density lipoprotein-cholesterol (non HDL-C).
FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
In December 2012, the FDA approved Juxtapid (lomitapide) to reduce LDL-C, total cholesterol, apolipoprotein B, and non HDL-C in patients with HoFH.
FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
Block it and you may reduce clotting around heart-threatening cholesterol plaques.
Researchers said giving patients the cholesterol-lowering drug Lipitor immediately -- regardless of their cholesterol levels -- could reduce the risk of death, new heart attacks and other bad outcomes by 16 percent.
Ultimately, cardiologists hope to create a powerful new triple-threat cocktail combining today's statin drugs for lowering bad cholesterol (like Lipitor) with new compounds to boost good cholesterol and other drugs that would directly reduce vessel-wall inflammation.
Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca and others are testing drugs that would reduce inflammation indirectly by raising the "good" HDL cholesterol that helps the body pump fat out of the arteries.
However, decades of clinical studies, studies that have cost literally BILLIONS of dollars have shown that lowering cholesterol to under 200 does, in fact, reduce heart attacks and strokes.
FORBES: Marcia Angell's Attacks on Pharma Have Lost all Credibility
Doctors recommend stopping smoking, limiting alcohol intake, lowering cholesterol and saturated fat intake and increasing physical activity to reduce the risk of stroke.
Dr. Nissen notes that the preventive effect of the diet is similar to the effect of taking statins, the cholesterol-lowering drugs, which research has shown to reduce the risk of major cardiovascular events by about 25% to 30%.
WSJ: Mediterranean Diet of Olive Oil, Nuts, Reduces Heart Disease, Study Finds
Existing cholesterol-lowering pills like Lipitor and AstraZeneca's Crestor reduce the risk of heart attack by at least a third.
They showed that Vytorin, a combination of the generic cholesterol drug Zocor and the newer medicine Zetia, did not reduce ultrasound readings of thickness in the neck artery any more than Zocor alone.
FORBES: Merck To Pay $688 Million To Shareholders For Delaying Vytorin Results
Along with helping heavy patients lose weight (it doesn't seem to work as well on thinner patients), Acomplia also raises good cholesterol, cuts bad cholesterol, reduces triglicerides and generally seems as if it should reduce the risk of heart disease and other obesity-related killers.
The drug is designed to boost high-density lipoprotein (HDL), nicknamed "good cholesterol" because it appears to actually clear plaque from the arteries and reduce the risk of heart attack.
Even before the results of the study, dubbed ProACTIVE, it had been shown to reduce inflammation in the arteries, which some experts believe could be more important than cholesterol in causing heart attacks.
D-4F also seems to reduce inflammation in the arteries, which many doctors believe is as big a risk factor as cholesterol itself.
He is, however, worried that people with high cholesterol would take relatively low doses when they should be taking higher ones to really reduce their risk of heart attacks.
应用推荐